Exagen Inc
Diagnostics & Research
Healthcare
XGN
18.25 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
3.99
52 week high
6.00
high
4.59
52 week low
1.74
previous Close
4.00
P/E ratio
market cap
88.54 M
div yield
0
net incoming
-5.03 M
-69.52 %
net profit margin
-40.20 %
-20.00 %
operating incoming
-4.66 M
-80.25 %
net change in cash
-2.24 M
19.51 %
cash on hand
22.04 M
-9.98 %
cost of revenue
5.53 M
-8.02 %
top